BRUSASCO, VITO
 Distribuzione geografica
Continente #
EU - Europa 22.179
Totale 22.179
Nazione #
IT - Italia 22.179
Totale 22.179
Città #
Genova 18.796
Rapallo 2.108
Genoa 1.234
Bordighera 41
Totale 22.179
Nome #
G(s) protein dysfunction in allergen-challenged human isolated passively sensitized bronchi. 157
Increase in airway responsiveness and effect of deep inhalation on airway caliber in allergen-induced asthma: relationship to the late-phase response. 154
Relationship between quasi-static pulmonary hysteresis and maximal airway narrowing in humans. 143
Allergen challenge of passively sensitized human bronchi alters M2 and Beta2 receptor function 140
Inspiratory capacity and decrease in lung hyperinflation with albuterol in COPD. 139
Severity grading of chronic obstructive pulmonary disease: the confounding effect of phenotype and thoracic gas compression 139
Lung elastic recoil during breathing at increased lung volume. 138
Beta-Adrenergic Agonists 135
Acute effects of indacaterol on lung hyperinflation in moderate COPD: a comparison with tiotropium. 134
Airway hyperresponsiveness with chest strapping: A matter of heterogeneity or reduced lung volume? 134
Acute bronchodilator responsiveness in bronchiolitis obliterans syndrome following hematopoietic stem cell transplantation 133
Self-assembled polyelectrolyte capsule for drug delivery: In vitro evaluation of their interaction with cell 130
Beclomethasone/formoterol in the management of COPD: a randomised controlled trial. 129
Computer-aided quantitative ultrasonography for detection of pulmonary edema in mechanically ventilated cardiac surgery patients 128
Airway distensibility and volume recruitment with lung inflation in COPD. 127
Coming together: the ATS/ERS consensus on clinical pulmonary function testing. 127
Noninflammatory mechanisms of airway hyper-responsiveness in bronchial asthma: an overview. 127
Measurement of pulmonary resistance and dynamic compliance with airway obstruction 126
Effects of κ- and μ-opioid agonists on cholinergic neurotransmission and contraction in isolated bovine trachealis 126
Bronchodilator effects of exercise hyperpnea and albuterol in mild-to-moderate asthma 125
Pre-junctional muscarinic autoreceptors in bovine airways. 125
Do Maximum Flow-Volume Loops Collected During Maximum Exercise Test Alter the Main Cardiopulmonary Parameters? 124
Allergy and sports: exercise-induced asthma. 124
Bronchial responsiveness is not increased by bronchoalveolar and bronchial lavage performed after allergen challenge. 124
The European Respiratory Journal makes COPD a priority. 123
Quantitative Analysis of Lung Ultrasonography for the Detection of Community-Acquired Pneumonia: A Pilot Study 123
Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. 122
Pulmonary function studies, still a priority in COPD 122
ERJ peer reviewers: does this pillar of the Journal's quality need help? 122
Effect of bronchodilatation on single breath pulmonary uptake of carbon monoxide in chronic obstructive pulmonary disease 122
Treatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA(2)LEN 121
Standardisation of lung function testing: the authors' replies to readers' comments. 121
Dissociation between exhaled nitric oxide and hyperresponsiveness in children with mild intermittent asthma. 121
Standardisation of the measurement of lung volumes. 121
Refining the changes. Or, how to modify the shape, not the spirit. 120
Airway distensibility with lung inflation after allogeneic haematopoietic stem-cell transplantation. 120
Deep breaths, methacholine, and aIRWAY NARROWING IN HEALTHY AND MILD ASTHMATIC SUBJECTS 119
Time course and calcium dependence of sustained bronchoconstriction induced by deep inhalation in asthma. 119
Cutaneous antihistaminic action of cetirizine and dose-related EEG concomitants of sedation in man. 119
A clinical trial of oral clenbuterol (NAB 365) in chronic airways obstruction. 119
Spirometric definition of COPD: exercise in futility or factual debate? 119
Debating the definition of airflow obstruction: time to move on? 118
Mechanical response to methacholine and deep inspiration in supine men. 118
The clinical and integrated management of COPD. An official document of AIMAR (Interdisciplinary Association for Research in Lung Disease), AIPO (Italian Association of Hospital Pulmonologists), SIMER (Italian Society of Respiratory Medicine), SIMG (Italian Society of General Medicine) 118
Inflammatory and mechanical factors of allergen-induced bronchoconstriction in mild asthma and rhinitis 117
Allergic inflammation and airway smooth muscle function 117
Effects of deep inhalation during early and late asthmatic reactions to allergen. 116
Outcomes for COPD pharmacological trials: from lung function to biomarkers. 115
Late-phase asthmatic reaction to inhaled allergen is associated with early recruitment of eosinophils in the airways. 114
Standardisation of spirometry. 113
Standardisation of the single-breath determination of carbon monoxide uptake in the lung. 113
Tiotropium versus salmeterol for the prevention of exacerbations of COPD. 113
Vital capacities in acute and chronic airway obstruction: dependence on flow and volume histories. 113
Lung function testing in COPD: when everything is not so simple 113
Airway responsiveness to methacholine and deep inhalations in subjects with rhinitis without asthma. 113
The ERJ in its 21st year of age: a smooth transition for an everlasting evolution 112
Analysis of nitrogen multibreath washout curves through a statistical approach. 111
Exercise-induced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: part I of the report from the Joint Task Force of the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA2LEN. 110
Airway hyperresponsiveness in asthma: not just a matter of airway inflammation 110
Assessing the effect of deep inhalation on airway calibre: a novel approach to lung function in bronchial asthma and COPD. 110
Lung hyperinflation in airway obstruction. 110
Regional expiratory flow limitation studied with Technegas in asthma. 109
Changes in lung volumes and airway responsiveness following haematopoietic stem cell transplantation 109
Quantitative analysis of peripheral allergen-specific B lymphocytes in asthma. 109
Effect of seasonal exposure to pollen on specific bronchial sensitivity in allergic patients. 109
Delivered volume during high-frequency ventilation. 109
Resonant amplification of delivered volume during high-frequency ventilation. 109
Mechanisms for reduced pulmonary diffusing capacity in haematopoietic stem-cell transplantation recipients. 109
Attenuation of induced-bronchoconstriction in healthy subjects: effects of breathing depth 108
Assessing airflow obstruction: when everything is not so obvious. 108
Airway inflammation and occurrence of delayed bronchoconstriction in exercise-induced asthma. 108
The use and misuse of Penh in animal models of lung disease. 108
Effect of nedocromil sodium on the late asthmatic reaction to bronchial antigen challenge. 108
Asthma management failure: a flaw in physicians' behavior or in patients' knowledge? 108
Complexity of factors modulating airway narrowing in vivo: relevance to assessment of airway hyperresponsiveness. 107
Airway responsiveness to methacholine: effects of deep inhalations and airway inflammation 107
Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma 107
On the causes of lung hyperinflation during bronchoconstriction. 106
Pulmonary physiology: future directions for lung function testing in COPD 106
Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. 105
Commentary on "The role of the large airways on smooth muscle contraction in asthma". 105
On the terminology for describing the length-force relationship and its changes in airway smooth muscle. 105
Effect of beta-adrenergic blockade on response to exercise in sedentary and active subjects. 105
Effects of lung volume and thoracic gas compression on maximal and partial flow-volume curves. 105
Bronchial provocation tests with RAST-standardized allergens and dosimetric technique. 104
Ventilation-perfusion relationship during high-frequency ventilation. 104
Commentaries on Viewpoint: Airway smooth muscle and airway hyperresponsiveness in human asthma: have we chased the wrong horse? 104
Effects of chest wall strapping on mechanical response to methacholine in humans. 104
Action other than smooth muscle relaxation may play a role in the protective effects of formoterol on the allergen-induced late asthmatic reaction 103
CPAP as a novel treatment for bronchial asthma? 103
Counterpoint: should we abandon FEV₁/FVC < 0.70 to detect airway obstruction? Yes. 103
Assessment of extravascular lung water by quantitative ultrasound and CT in isolated bovine lung 103
Breathing during exercise in subjects with mild-to-moderate airflow obstruction: effects of physical training. 103
What can we learn from pulmonary function testing in heart failure? 103
Formoterol by pressurized metered-dose aerosol or dry powder on airway obstruction and lung hyperinflation in partially reversible COPD 103
Gas exchange and intrapulmonary distribution of ventilation during continuous-flow ventilation. 102
Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids. 102
Impact factor and its role in academic promotion. 101
Usefulness of peak expiratory flow measurements: is it just a matter of instrument accuracy? 101
Nimesulide does not interfere with airway responsiveness in allergic asthma. 101
Totale 11.628
Categoria #
all - tutte 46.664
article - articoli 45.991
book - libri 0
conference - conferenze 673
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.328


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.557 0 0 0 0 0 0 0 0 0 310 702 545
2019/20206.766 255 174 331 391 636 659 1.318 427 602 1.058 648 267
2020/20211.449 94 113 156 118 76 142 74 132 178 156 109 101
2021/20222.707 53 103 98 324 261 211 146 590 169 371 60 321
2022/20232.530 274 88 19 266 396 574 7 221 480 14 155 36
2023/2024855 62 150 11 102 131 218 57 44 59 21 0 0
Totale 22.233